SIC
ADMA icon

SJS Investment Consulting’s ADMA Biologics ADMA Stock Holding History

SJS Investment Consulting’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13K Buy
255
+211
+480% +$1.92K ﹤0.01% 1751
2026
Q1 		$397 Buy
44
+32
+267% +$505 ﹤0.01% 1820
2025
Q4 		$219 Hold
12
– – ﹤0.01% 1781
2025
Q3 		$176 Hold
12
– – ﹤0.01% 1489
2025
Q2 		$219 Sell
12
-59
-83% -$1.2K ﹤0.01% 1352
2025
Q1 		$1.41K Hold
71
– – ﹤0.01% 868
2024
Q4 		$1.22K Buy
71
+43
+154% +$809 ﹤0.01% 928
2024
Q3 		$560 Buy
+28
New +$435 ﹤0.01% 1289

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

SJS Investment Consulting's ADMA Position: Q2 2026 in Review

SJS Investment Consulting increased its ADMA Biologics (ADMA) stake by 480% in Q2 2026, buying an estimated $1.92K and bringing the position to 255 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

SJS Investment Consulting first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. 79 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • SJS Investment Consulting held 255 shares of ADMA Biologics worth $2.13K as of Q2 2026.
  • SJS Investment Consulting bought 211 ADMA Biologics shares in Q2 2026, an estimated $1.92K.
  • ADMA Biologics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1751 holding.
  • SJS Investment Consulting first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • 79 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.